Local pharmacists are keeping a close eye on legislators considering a bill supporters say will bring transparency to how pharmacy benefit managers operate.

Employees filing pioneering suits against companies like JPMorgan Chase & Co. and Johnson & Johnson over prescription drug ...

President Donald Trump’s firing this week of two Democratic members of the Federal Trade Commission calls into question how ...

The firing of the Federal Trade Commission’s (FTC’s) two remaining Democratic commissioners Wednesday could raise new, ...

President Donald Trump’s move to fire two Democrats on the Federal Trade Commission leaves a question mark over the future of ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The PBM plans to stop requiring coverage reauthorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...

JPMorgan Chase mismanaged employee health benefits, resulting in past and present employees paying inflated prices for ...

The massive pharmacy benefit manager plans to stop requiring coverage reauthorizations for roughly 80 drugs used to treat ...

Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with ...

The list, which could be expanded over time, will eliminate up to 25% of these reauthorization requirements and accounts for ...

A pharmacy benefit manager negotiates prices with wholesalers, sets reimbursement rates on drugs and compiles the lists of which medicines an insurer will cover. But critics describe the industry as ...